Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-21-010317
Filing Date
2021-08-23
Accepted
2021-08-23 15:30:07
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27620
2 filename2.txt TEXT-EXTRACT 1412
  Complete submission text file 0000000000-21-010317.txt   40247
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filed for) CIK: 0001541157 (see all company filings)

EIN.: 981034922 | State of Incorp.: X0
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations